The store will not work correctly when cookies are disabled.
US9062043, Table 20, Compound 8
ID: ALA3700566
PubChem CID: 50941657
Max Phase: Preclinical
Molecular Formula: C19H13N5S
Molecular Weight: 343.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(Nc2nc3cc(-c4nnc[nH]4)ccc3c3sccc23)cc1
Standard InChI: InChI=1S/C19H13N5S/c1-2-4-13(5-3-1)22-19-15-8-9-25-17(15)14-7-6-12(10-16(14)23-19)18-20-11-21-24-18/h1-11H,(H,22,23)(H,20,21,24)
Standard InChI Key: WWHTXFXEFKFDIR-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
2.6003 -1.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2007 -1.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4972 -0.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4920 0.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1903 1.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8939 0.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2991 3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 -1.7530 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2991 5.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0869 6.1125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5527 7.5384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0527 7.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5140 6.1087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
1 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 8 1 0
20 16 2 0
12 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.42 | Molecular Weight (Monoisotopic): 343.0892 | AlogP: 4.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 66.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.91 | CX Basic pKa: 3.53 | CX LogP: 3.99 | CX LogD: 3.99 |
Aromatic Rings: 5 | Heavy Atoms: 25 | QED Weighted: 0.48 | Np Likeness Score: -1.65 |
References
1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators, |